Palm Beach Gardens Medical Center Introduces Prostate Biopsy Option with MRI Precision Targeting
Aug 24, 2020Targeted MRI/Ultrasound Fusion biopsies are one of the latest technologies available in the detection and management of prostate cancer. Palm Beach Gardens Medical Center is proud to offer this new standard of care.
Historically, finding the exact location of cancer in a prostate gland has been a challenge. Conventional TRUS prostate biopsy techniques are referred to as “blind” biopsies since physicians typically cannot easily view the specific location of any abnormal tissue. Now, using the Artemis 3D imaging and navigation system, physicians are able to better identify and more accurately biopsy suspicious prostate cancer areas.
“Having this technology at Palm Beach Gardens Medical Center is a boost to healthcare in this community,” said Teresa Urquhart, chief executive officer at Palm Beach Gardens Medical Center. “We are committed to our patients to be here for them when they need us most, and we can provide them with this enhanced level of care in a safe and secure environment.”
The MRI/Ultrasound Fusion (or MR/US Fusion) targeted biopsy procedure starts by using pre-exam MRI prostate images. These images are then fused with real-time ultrasound images to create a detailed 3D high-definition map of the prostate. This allows the physician to accurately target any visible lesions during the biopsy.
Patients recommended for this procedure are men who, typically, have elevated and/or rising prostate-specific antigen (PSA) levels or those with a clinical concern for prostate cancer.
According to the American Cancer Society, prostate cancer is the second most common cancer in men after skin cancer, and one in seven men will be diagnosed in his lifetime. Prostate cancer can be a serious disease, but with early detection, most men have a 5 year survival rate of 90%.
